Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial.
Saved in:
| Title: | Author Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial. |
|---|---|
| Authors: | Houot R; Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France. roch.houot@chu-rennes.fr., Bachy E; Department of Hematology, Lyon Sud Hospital Center, INSERM U1111, Lyon, France., Cartron G; Department of Hematology, University Hospital of Montpellier, UMR-CNRS 5535, Montpellier, France., Gros FX; Department of Clinical Hematology and Cellular Therapy, University Hospital of Bordeaux, Bordeaux, France., Morschhauser F; ULR 7365 - GRITA, University Hospital of Lille, Lille, France., Oberic L; Department of Hematology, Cancer University Institute of Toulouse Oncopole, Toulouse, France., Gastinne T; Department of Hematology, University Hospital of Nantes, Nantes, France., Feugier P; Department of Hematology, University Hospital of Nancy, INSERM 1256, University of Lorraine, Vandœuvre-lès-Nancy, France., Duléry R; Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMR938, Paris, France., Thieblemont C; Department of Hematology and Oncology, Saint-Louis Hospital, AP-HP, Paris, France., Joris M; Department of Hematology, University Hospital of Amiens, Amiens, France., Jardin F; Department of Clinical Hematology, Henri Becquerel Center, INSERM U1245, Rouen, France., Choquet S; Department of Hematology, University Hospital Pitié Salpêtrière, AP-HP, Sorbonne University, Paris, France., Casasnovas O; Department of Clinical Hematology, Dijon University Hospital, INSERM UMR1231, Dijon, France., Brisou G; Department of Hematology, Institut Paoli-Calmettes, Marseille, France., Cheminant M; Department of Clinical Hematology, Necker-Enfants Malades University Hospital, AP-HP, INSERM UMR1163, Paris, France., Bay JO; Department of Clinical Hematology and Cellular Therapy, Clermont-Ferrand University Hospital Center, Clermont-Ferrand, France., Gutierrez FL; Department of Anatomopathology, University Hospital of Rennes, Rennes, France., Menard C; French Blood Establishment and SITI Laboratory, UMR U1236, INSERM, University of Rennes, University Hospital Center of Rennes, Rennes, France., Tarte K; French Blood Establishment and SITI Laboratory, UMR U1236, INSERM, University of Rennes, University Hospital Center of Rennes, Rennes, France., Delfau MH; Department of Immunology, Henri Mondor Hospital, Créteil, France., Portugues C; Department of Biostatistics, LYSARC, Lyon-Sud Hospital, Pierre-Bénite, France., Itti E; Department of Nuclear Medicine, Henri Mondor Hospital, Créteil, France., Palard-Novello X; Department of Nuclear Medicine, University of Rennes, CLCC Eugène Marquis, INSERM, Rennes, France., Blanc-Durand P; Department of Nuclear Medicine, CHU H. Mondor, U-PEC, AP-HP, Créteil, France., Al Tabaa Y; Scintidoc Nuclear Medicine Center, Clinique Clémentville, Montpellier, France., Bailly C; Nantes-Angers Cancer Research Center CRCI2NA, University of Nantes, INSERM UMR1307, CNRS-ERL6075, Nantes, France., Laurent C; Department of Pathology, Cancer University Institute of Toulouse Oncopole, CHU Toulouse, CRCT INSERM U1037, Toulouse, France., Lemonnier F; Lymphoid Malignancies Unit, Henri Mondor Hospital, Mondor Institute for Biomedical Research, INSERM U955, University Paris-Est, Créteil, France. |
| Source: | Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 2089. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
